Google Cloud's updated its Vertex AI platform to support AI agents with including the Agent Development Kit, the Agent2Agent ...

This was the stock's second consecutive day of gains.

DA Davidson lowered the firm’s price target on Vertex (VERX) to $50 from $55 and keeps a Buy rating on the shares as part of a broader research ...

Learn more about whether Alkami Technology, Inc. or Vertex, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Vertex Pharmaceuticals Inc. closed 8.54% short of its 52-week high of $519.88, which the company achieved on November 8th.

UiPath (NYSE: PATH), a leading enterprise automation and AI software company, today announced at Google Cloud Next 2025 the launch of its generative AI-based UiPath Medical Record Summarization agent, ...

Google is adding a new open source framework for building agents to its AI and machine learning platform Vertex AI, along ...

Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain and other markets. Check out our ...

A memorandum opinion by Chief Judge James E. Boasberg of the US District Court for the District of Columbia upheld a US Department of Health and Human Services advisory opinion that found that Vertex ...

The best free writing app and software helps you get your ideas down on the page, with tools to help manage, organize, and plot your latest work. My team and I have tested a range of the best free ...

We list the best typing tutor software, to make it simple and easy to improve your typing skills with a computer. After all, whether you're using a desktop of laptop, you'll need to be able to ...

The forward-looking statements contained in this Press Release are based on the expectations, estimates and projections of management of Vertex as of the date of this Press Release unless ...